ArticleFrontiers in endocrinology2026
Real-world use of semaglutide in patients with type 2 diabetes and end-stage renal disease: a multicenter retrospective cohort study.
Omar Alkhezi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.